Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 16Recruiting 9Unknown 6Withdrawn 3Terminated 2Not yet recruiting 2Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Anorexia Nervosa with Significantly Low Body Weight 1

Interventions

Specimen Handling 7Educational Status 7Cisplatin 7Standard of Care 6Interviews as Topic 6Blood Specimen Collection 6Radiotherapy 5Nivolumab 5Chemoradiotherapy 5Carboplatin 5Surgical Procedures, Operative 4Paclitaxel 4Oxaliplatin 4Fluorouracil 4Drug Therapy 4lenvatinib 3camrelizumab 3Surveys and Questionnaires 3Practice Guidelines as Topic 3Patient Navigation 3Methods 3Magnetic Resonance Spectroscopy 3Magnetic Resonance Imaging 3Lenalidomide 3Gemcitabine 3Fluorodeoxyglucose F18 3Exercise 3Early Intervention, Educational 3Dexamethasone 3Cytarabine 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × OTHER × Olanzapine × Clear all
NCT05170919 2024-09-19

Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer

Englewood Hospital and Medical Center

Phase 2 Enrolling by invitation
170 enrolled

Anorexia Nervosa with Significantly Low Body Weight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡